MTL-301

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMTL-301
Drug Alias NameMTL-301
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMina Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCity of HopeImperial College LondonMina Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A